All Posts

October 2025 Crainio is delighted to announce the appointment of Alex Stokoe  as Head of Product . Alex joins the company from TTP (The Technology Partnership) , where he led the Neurotechnology group , overseeing the development of pioneering medical and neurotech products from concept to clinical deployment. At Crainio, Alex will play a central role in guiding the company’s product through its regulatory pathway to CE accreditation  and onward to commercial launch . His ext

September 2025 Crainio is proud to announce that the United States Patent and Trademark Office (USPTO)  has granted its patent  covering the use of photoplethysmography (PPG)  for non-invasive intracranial pressure (ICP) measurement . This patent represents a major milestone in Crainio’s mission to develop accurate, accessible tools for assessing brain health without the risks associated with invasive monitoring. The newly granted intellectual property strengthens Crainio’s g

August 2025 We’re thrilled to announce that Crainio has successfully closed its seed funding round , backed by a group of angel investors and the NLC Health Impact Fund . This investment marks a major milestone in our mission to bring Crainio’s innovative technology to clinical-grade reliability — meeting standard-of-care levels of accuracy  for use in real-world healthcare settings. The funding will also support our progress toward hardware design freeze , ensuring our solut

April 2025 We’re excited to announce the start of our feasibility study , supported by an Innovate UK Biomedical Catalyst grant , to advance Crainio’s non-invasive intracranial hypertension measurement technology  toward standard-of-care accuracy . The study is being conducted in the Intensive Care Unit of The Royal London Hospital , led by Professor Chris Uff , Consultant Neurosurgeon. This marks a major milestone as we work to make accurate, safe, and accessible brain press